Mark Kemp joined Frazier Healthcare Partners as an Operating Partner on the Growth Buyout team to assist the firm with opportunities in the pharma services space.
Mr. Kemp came to Frazier with a broad base of leadership experience in business development, M&A, operations, supply chain and R&D. Most recently he was President & Chief Executive Officer of Tecomet, a Charlesbank portfolio company and global leader of supply chain solutions serving the medical device and aerospace/defense markets. Founded in 1963 and headquartered in Woburn, MA, Tecomet operates sixteen (16) global manufacturing facilities in five countries around the world with approximately 3000 employees. Mr. Kemp also served as President & COO and as a member of Tecomet’s Board of Directors.
Prior to Tecomet, Mr. Kemp was President of Flextronics Medical, a business division of Flextronics (NASDAQ: FLEX), and the global leader of medical supply chain solutions serving the medical device, diagnostics, and pharmaceuticals industries. In his 17 years with Flextronics, Mr. Kemp also served as Senior Vice President & General Manager of Medical Devices, a division under Flextronics Medical serving the medical devices, drug delivery, and disposables markets. He also served as Vice President of Consumer Health & Drug Delivery where he was responsible for operations, R&D, business development and related commercial functions.
Prior to joining Flextronics, Mark had over 20 years’ managerial experience in business development, operations, supply chain and M&A with Aerospace and Defense companies (Pratt & Whitney Aircraft and Sparton Electronics) and a mid-tier contract manufacturer (XeTel Corporation).
Mr. Kemp is a graduate of the Stanford Executive Leadership Development Program and holds a Bachelor of Science in Mechanical Engineering from the University of Florida and a Master of Business Administration in Aviation from Embry-Riddle Aeronautical University.
Embry-Riddle Aeronautical University (M.B.A)
University of Florida (B.S.)